High levels of GRPR-expression have been indeed documented in excised patient biopsy specimens from prostate cancer (PC), especially in its early stages [4,5,6,7,8], breast cancer [9,10,11], gastrointestinal stroma tumors [12] and other human cancers [13,14]. Here, GRPR is linked to pachyonychia congenita.